West Pharmaceutical Services Comprehensive Income 2010-2024 | WST
West Pharmaceutical Services comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- West Pharmaceutical Services comprehensive income for the quarter ending September 30, 2024 was $-0.136B, a 38.88% decline year-over-year.
- West Pharmaceutical Services comprehensive income for 2023 was $-0.144B, a 21.42% decline from 2022.
- West Pharmaceutical Services comprehensive income for 2022 was $-0.183B, a 14.66% increase from 2021.
- West Pharmaceutical Services comprehensive income for 2021 was $-0.16B, a 44.3% increase from 2020.
West Pharmaceutical Services Annual Comprehensive Income
(Millions of US $) |
| 2023 |
$-144 |
| 2022 |
$-183 |
| 2021 |
$-160 |
| 2020 |
$-111 |
| 2019 |
$-150 |
| 2018 |
$-154 |
| 2017 |
$-117 |
| 2016 |
$-187 |
| 2015 |
$-163 |
| 2014 |
$-119 |
| 2013 |
$-32 |
| 2012 |
$-76 |
| 2011 |
$-72 |
| 2010 |
$-31 |
| 2009 |
$-20 |
West Pharmaceutical Services Quarterly Comprehensive Income
(Millions of US $) |
| 2024-09-30 |
$-136 |
| 2024-06-30 |
$-217 |
| 2024-03-31 |
$-192 |
| 2023-12-31 |
$-144 |
| 2023-09-30 |
$-223 |
| 2023-06-30 |
$-184 |
| 2023-03-31 |
$-168 |
| 2022-12-31 |
$-183 |
| 2022-09-30 |
$-309 |
| 2022-06-30 |
$-246 |
| 2022-03-31 |
$-182 |
| 2021-12-31 |
$-160 |
| 2021-09-30 |
$-156 |
| 2021-06-30 |
$-133 |
| 2021-03-31 |
$-140 |
| 2020-12-31 |
$-111 |
| 2020-09-30 |
$-160 |
| 2020-06-30 |
$-188 |
| 2020-03-31 |
$-192 |
| 2019-12-31 |
$-150 |
| 2019-09-30 |
$-170 |
| 2019-06-30 |
$-152 |
| 2019-03-31 |
$-153 |
| 2018-12-31 |
$-154 |
| 2018-09-30 |
$-154 |
| 2018-06-30 |
$-144 |
| 2018-03-31 |
$-96 |
| 2017-12-31 |
$-117 |
| 2017-09-30 |
$-131 |
| 2017-06-30 |
$-152 |
| 2017-03-31 |
$-179 |
| 2016-12-31 |
$-187 |
| 2016-09-30 |
$-144 |
| 2016-06-30 |
$-150 |
| 2016-03-31 |
$-148 |
| 2015-12-31 |
$-163 |
| 2015-09-30 |
$-154 |
| 2015-06-30 |
$-160 |
| 2015-03-31 |
$-170 |
| 2014-12-31 |
$-119 |
| 2014-09-30 |
$-71 |
| 2014-06-30 |
$-35 |
| 2014-03-31 |
$-34 |
| 2013-12-31 |
$-32 |
| 2013-09-30 |
$-70 |
| 2013-06-30 |
$-91 |
| 2013-03-31 |
$-93 |
| 2012-12-31 |
$-76 |
| 2012-09-30 |
$-72 |
| 2012-06-30 |
$-89 |
| 2012-03-31 |
$-59 |
| 2011-12-31 |
$-72 |
| 2011-09-30 |
$-25 |
| 2011-06-30 |
$-1 |
| 2011-03-31 |
$-11 |
| 2010-12-31 |
$-31 |
| 2010-09-30 |
$-28 |
| 2010-06-30 |
$-65 |
| 2010-03-31 |
$-37 |
| 2009-12-31 |
$-20 |
| 2009-09-30 |
$-19 |
| 2009-06-30 |
$-31 |
| 2009-03-31 |
$-56 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$22.928B |
$2.950B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
